Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.

Snyder EL, Sekela ME, Welsby IJ, Toyoda Y, Alsammak M, Sodha NR, Beaver TM, Pelletier JPR, Gorham JD, McNeil JS, Sniecinski RM, Pearl RG, Nuttall GA, Sarode R, Reece TB, Kaplan A, Davenport RD, Ipe TS, Benharash P, Lopez-Plaza I, Gammon RR, Sadler P, Pitman JP, Liu K, Bentow S, Corash L, Mufti N, Varrone J, Benjamin RJ, for the ReCePI study group

Open source

DOI: 10.1186/s13063-023-07831-x
Published: 2023 Dec 11
Container: Trials
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-023-07831-x,
  title = {Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.},
  author = {Snyder EL and Sekela ME and Welsby IJ and Toyoda Y and Alsammak M and Sodha NR and Beaver TM and Pelletier JPR and Gorham JD and McNeil JS and Sniecinski RM and Pearl RG and Nuttall GA and Sarode R and Reece TB and Kaplan A and Davenport RD and Ipe TS and Benharash P and Lopez-Plaza I and Gammon RR and Sadler P and Pitman JP and Liu K and Bentow S and Corash L and Mufti N and Varrone J and Benjamin RJ and for the ReCePI study group},
  year = {2023},
  journal = {Trials},
  doi = {10.1186/s13063-023-07831-x},
  url = {https://doi.org/10.1186/s13063-023-07831-x}
}

RIS

TY  - JOUR
TI  - Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.
AU  - Snyder EL
AU  - Sekela ME
AU  - Welsby IJ
AU  - Toyoda Y
AU  - Alsammak M
AU  - Sodha NR
AU  - Beaver TM
AU  - Pelletier JPR
AU  - Gorham JD
AU  - McNeil JS
AU  - Sniecinski RM
AU  - Pearl RG
AU  - Nuttall GA
AU  - Sarode R
AU  - Reece TB
AU  - Kaplan A
AU  - Davenport RD
AU  - Ipe TS
AU  - Benharash P
AU  - Lopez-Plaza I
AU  - Gammon RR
AU  - Sadler P
AU  - Pitman JP
AU  - Liu K
AU  - Bentow S
AU  - Corash L
AU  - Mufti N
AU  - Varrone J
AU  - Benjamin RJ
AU  - for the ReCePI study group
PY  - 2023
JO  - Trials
DO  - 10.1186/s13063-023-07831-x
UR  - https://doi.org/10.1186/s13063-023-07831-x
ER  -

APA

EL, S., ME, S., IJ, W., Y, T., M, A., NR, S., TM, B., JPR, P., JD, G., JS, M., RM, S., RG, P., GA, N., R, S., TB, R., A, K., RD, D., TS, I., P, B., I, L., RR, G., P, S., JP, P., K, L., S, B., L, C., N, M., J, V., RJ, B., & group, F. T. R. S. (2023). Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.. Trials. https://doi.org/10.1186/s13063-023-07831-x

Source records

pubmed · retrieved 2026-09-26T15:59:18.786Z